JSI‐124 inhibits cell proliferation and tumor growth by inducing autophagy and apoptosis in murine malignant mesothelioma

Malignant pleural mesothelioma (MPM), mainly caused by asbestos exposure, has a poor prognosis and lacks effective treatment compared with other cancer types. The intracellular transcription factor signal transducer and activator of transcription 3 (STAT3) is overexpressed and hyperactivated in most human cancers. In this study, the role of STAT3 in murine MPM was examined. Inhibition of the Janus kinase 2 (JAK2)/STAT3 pathway with the selective inhibitor JSI-124 has an antitumor effect in murine MPM. Specifically, we demonstrated that JSI-124 inhibits murine MPM cell growth and induces apoptotic and autophagic cell death. Exposure of RN5 and AB12 cells to JSI-124 resulted in apoptosis via the Bcl-2 family of proteins. JSI-124 triggered autophagosome formation, accumulation, and conversion of LC3I to LC3II. Autophagy inhibitors, Chloroquine (CQ) and Bafilomycin A1 (Baf-A1), inhibited autophagy and sensitized RN5 and AB12 cells to JSI-124-induced apoptosis. Our data indicate that JSI-124 is a promising therapeutic agent for MPM treatment.

[1]  P. Pinton,et al.  Molecular Mechanisms of Autophagy in Cancer Development, Progression, and Therapy , 2022, Biomedicines.

[2]  A. Mansfield,et al.  First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743. , 2022, Annals of oncology : official journal of the European Society for Medical Oncology.

[3]  M. Ernst,et al.  Multicellular Effects of STAT3 in Non-small Cell Lung Cancer: Mechanistic Insights and Therapeutic Opportunities , 2021, Cancers.

[4]  V. Adam,et al.  Signal transducer and activator of transcription 3 signaling in tumor immune evasion. , 2021, Pharmacology & therapeutics.

[5]  M. de Perrot,et al.  Carbon Nanotubes: A Summary of Beneficial and Dangerous Aspects of an Increasingly Popular Group of Nanomaterials , 2021, Frontiers in Oncology.

[6]  R. Bruggmann,et al.  Malignant pleural mesothelioma co-opts BCL-XL and autophagy to escape apoptosis , 2021, Cell death & disease.

[7]  C. Paweletz,et al.  Inhibitors of the Transcription Factor STAT3 Decrease Growth and Induce Immune Response Genes in Models of Malignant Pleural Mesothelioma (MPM) , 2020, Cancers.

[8]  Qiuju Han,et al.  STAT3: A key signaling molecule for converting cold to hot tumors. , 2020, Cancer letters.

[9]  Shi-kun He,et al.  Autophagy and autophagy-related proteins in cancer , 2020, Molecular Cancer.

[10]  Chaoyue Sun,et al.  Targeting STAT3 inhibition to reverse cisplatin resistance. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[11]  M. de Perrot,et al.  Curcumin induces apoptosis and inhibits angiogenesis in murine malignant mesothelioma , 2018, International journal of oncology.

[12]  Chang-Qi Zhu,et al.  Putative cancer stem cells may be the key target to inhibit cancer cell repopulation between the intervals of chemoradiation in murine mesothelioma , 2018, BMC Cancer.

[13]  W. Richards,et al.  Inhibition of autophagy initiation potentiates chemosensitivity in mesothelioma , 2018, Molecular carcinogenesis.

[14]  Jennifer R. Grandis,et al.  Targeting the IL-6/JAK/STAT3 signalling axis in cancer , 2018, Nature Reviews Clinical Oncology.

[15]  Xiaoxiao Sun,et al.  Cucurbitacin I inhibits STAT3, but enhances STAT1 signaling in human cancer cells in vitro through disrupting actin filaments , 2017, Acta Pharmacologica Sinica.

[16]  Nick A Maskell,et al.  Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment , 2016, European Respiratory Review.

[17]  X. Ding,et al.  Low nanomolar concentrations of Cucurbitacin-I induces G2/M phase arrest and apoptosis by perturbing redox homeostasis in gastric cancer cells in vitro and in vivo , 2016, Cell Death and Disease.

[18]  R. Bueno,et al.  Autophagy Correlates with the Therapeutic Responsiveness of Malignant Pleural Mesothelioma in 3D Models , 2015, PloS one.

[19]  J. Snowden,et al.  The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours , 2015, British Journal of Cancer.

[20]  R. Stahel,et al.  Inhibition of autophagy sensitizes malignant pleural mesothelioma cells to dual PI3K/mTOR inhibitors , 2015, Cell Death and Disease.

[21]  B. Schwaller,et al.  Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line , 2015, In Vitro Cellular & Developmental Biology - Animal.

[22]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[23]  A. Zoubeidi,et al.  The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer , 2014, Cancers.

[24]  Yoonjung Lee,et al.  Cucurbitacin induces autophagy through mitochondrial ROS production which counteracts to limit caspase-dependent apoptosis , 2012, Autophagy.

[25]  J. Gu,et al.  JSI-124 inhibits glioblastoma multiforme cell proliferation through G2/M cell cycle arrest and apoptosis augmentation , 2008, Cancer biology & therapy.

[26]  T. Noda,et al.  Dissection of the Autophagosome Maturation Process by a Novel Reporter Protein, Tandem Fluorescent-Tagged LC3 , 2007, Autophagy.

[27]  Lokesh Kumar,et al.  Mfuzz: A software package for soft clustering of microarray data , 2007, Bioinformation.

[28]  Kanyawim Kirtikara,et al.  Sulforhodamine B colorimetric assay for cytotoxicity screening , 2006, Nature Protocols.

[29]  J. Turkson,et al.  Discovery of JSI-124 (cucurbitacin I), a selective Janus kinase/signal transducer and activator of transcription 3 signaling pathway inhibitor with potent antitumor activity against human and murine cancer cells in mice. , 2003, Cancer research.

[30]  J. Wagner,et al.  Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province , 1960, British journal of industrial medicine.

[31]  B Terracini,et al.  Multicentric study on malignant pleural mesothelioma and non-occupational exposure to asbestos , 2000, British Journal of Cancer.